A founding member of ICON Bill Taaffe and Teckro’s Brendan Buckley discuss why sites need better support and why they’re not getting it.

Innovation consultant Tom Julian joins Teckro’s Malia Lewin to discuss the good, the bad and the ugly of clinical trial innovation.

CEO of Hightower Clinical Brad Hightower talks about leveraging LinkedIn to prompt open conversations between sites and sponsors.

Monica Cuitiva and Judy Galindo from Latinos in Clinical Research join us to discuss the workforce shortage in clinical research.

Global Head of Bioethics at Roche, Katrina Bramstedt, discusses the crucial role of bioethics in medical decision-making and how it supports patient centricity.

Robbyn Mattei discusses the necessary changes to South Africa’s clinical trials industry, including culture, funding, technology and staff retention challenges.

Lilly Skok Bunch of non-profit Greater Gift discusses the unique patient-oriented mission of showing gratitude to clinical trial participants as well as tackling DEI issues.

Grayson Scott of Centricity Research joins the podcast to explain how Teckro’s convenience and ease-of-use helps him better-serve patients.

Jenn Weinberg discusses how she found herself working in oncology and ways she sees Teckro can simplify clinical trials.

Steph Anderson, chief people officer at Meridian Clinical Research, joins us to discuss the company’s diversity initiative and the importance of relatable site staff.

Director of Site Engagement Silvina Baudino returns to tell exciting tales about supporting new sites through Teckro Powered, with big plans to expand the program.

Peter Gray, former-ICON CEO and Teckro chairman, shares his thoughts on industry trends and opportunities for clinical trial innovation.

The Clearity Foundation's Dr. Anne Mette Buhl explains the reality of clinical research as an early treatment option and the importance of oncology trial participation criteria.

Meridian's Nikki Osborn explains the success owed to an employee-focussed culture and how an uplifting environment with core values led to a thriving site network.

Sustainability maybe isn't a word that you immediately associate with clinical trials. And the reality is that there are inefficiencies throughout the trial process that actually work against creating a greener planet. On World Earth Day, Jeanne Hecht of JTH Consulting and Teckro's Malia Lewin reflect on what sustainability means in clinical research and the impact of Teckro, including how more streamlined communications leads to less travel, more trial efficiency, and a greener approach.

Teckro’s General Manager of R&D Products, Sonia Araujo, discusses the incredibly moving blog she wrote about her aunt Lena’s brain tumor diagnosis. From waking up one day with blurred vision, to having to face the terrible reality of grade 4 gliosarcoma – a rare type of brain cancer – Sonia elaborates on her aunt’s journey and explores some of the ways to improve patient care.

This week we’re joined by Silvina and Maria, both Teckro employees, as they compare notes on their past lives working in clinical research and reflect on the pivotal role of clinical research associates (CRAs). Silvina Baudino, director of site engagement, together with solutions consultant Maria Milas talk about how CRAs are the “glue” of trials, overseeing multiple sites and building strong working relationships with research staff. With topics ranging from lifelong friendships they made...

Cindy Jackson from the Institute for Advanced Clinical Trials in Children describes pediatric drug development complexities, study design issues and the need for fast trial referrals as standard care.

Centricity Research's Courtney Alexander explains how community-based research sites support physicians by freeing up time so they can focus on the most important part of clinical trials: the patient.

Marty Anderson on why she made the switch from CROs to sites, her experience in an Ebola “war room,” and why she felt it was her and her family’s duty to take part in the COVID-19 vaccine trials.

Cassadie Moravek from the Pancreatic Cancer Action Network talks about game-changing biomarkers and genetic testing to combat the deadly disease.

We talk to Daré Bioscience President and CEO Sabrina Johnson about her perspective on the advancements women have made in the biotech industry, why good things happen when we're not afraid to take a leap, and how adopting a mindful approach in our professional lives helps us separate legitimate progress from pointless activity.

What started as a slight tremor in her right hand led to the unwelcome discovery of Parkinson’s Disease at just 38. Ten years later, full-time “eternal optimist” and determined advocate Cathy Molohan shares her thoughts on deep brain stimulation, why exercise is so important to manage symptoms and the never-ending quest for a Parkinson's cure.

To mark World Cancer Day, UICC Campaign Manager Janine Huguenin discusses the push for equity and fairness in oncology care.

Pharmaceutical executive and consultant Dairine Dempsey urges women not to second-guess their ability, stresses the importance of emotional intelligence in the workplace, and highlights the need to address the lack of female representation at a senior level.